Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Subsidiary GenoVision Licenses DNA Extraction Method from Generation Biotech

NEW YORK, Feb. 15 (GenomeWeb News) - Qiagen said today that its wholly owned subsidiary GenoVision has licensed technology for haplotype-specific extraction of DNA from Lawrenceville, NJ-based Generation Biotech.

 

Under the terms of the agreement, GenoVision receives exclusive rights for the worldwide commercialization of the haplotype-specific extraction in all applications. Further financial terms were not disclosed.

 

The haplotype-specific extraction method physically separates DNA into its maternal and paternal alleles, enabling researchers or clinicians to determine the exact location of a mutation on both copies of the genome, Qiagen said.

 

Qiagen also said that the technology has been validated for use with a suite of its magnetic bead-based and automated DNA-purification technology.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.